Valeo Pharma (VPH.C) announced they have entered into a Product Listing Agreement (PLA) with the Executive Officer of the Ontario Public Drug Program for the listing of Redesca and…
Pharmaceuticals
InMed Pharmaceuticals (IN.T) has filed clinical trial applications (CTAs) in Austria, Israel and Serbia as part of a phase 2 clinical trial of INM-755, the Company’s cannabinol cream used…
“Psilocybin offers a potential solution to manage moderate to severe cases of TBI,” stated RVV, “Psilocybin has the potential with its neuroreparative effect to improve loss of cognitive function…
Tetra Bio-Pharma (TBP.T) has shipped Qixleef, its investigational new drug, to the United States for initiation of the REBORN1 study. The REBORN1 study will investigate cannabis as an alternative…
Valeo Pharma (VPH.C) announced they have begun shipments across Canada of Redesca and Redesca HP, their low molecular weight heparin (LMWH) biosimilar. Valeo has licensed Redesca from Shenzhen Techdow…
Valeo Pharma (VPH.C) has announced a non-brokered private placement of up to 4,000 unsecured non-convertible debentures units a a price of $1000 per unit for maximum gross proceeds of…
Agraflora Organics’ (AGRA.C) wholly owned subsidiary, Farmako GmbH, has begun supplying its THC test kits to STADAPHARM GmbH. “Katrin and everyone at Farmako continue to demonstrate their ingenuity and…
Information technology is ushering in a new paradigm for the healthcare sector. This is fundamentally changing how and where medical services are rendered, and decisions are made. From…
Naturally Splendid (NSP.V) has provided an update regarding a Health Canada approved clinical trial and strategic outlook for the development of Cavaltinib™. “We have been working with Franco and…
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to read much further. To…